AU2019342426A1 - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents

Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness Download PDF

Info

Publication number
AU2019342426A1
AU2019342426A1 AU2019342426A AU2019342426A AU2019342426A1 AU 2019342426 A1 AU2019342426 A1 AU 2019342426A1 AU 2019342426 A AU2019342426 A AU 2019342426A AU 2019342426 A AU2019342426 A AU 2019342426A AU 2019342426 A1 AU2019342426 A1 AU 2019342426A1
Authority
AU
Australia
Prior art keywords
composition
patient
dryness
ocular surface
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019342426A
Other languages
English (en)
Inventor
Markus Beier
Sonja KRÖSSER
Thomas SCHLÜTER
Daniela WILLEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novaliq GmbH
Original Assignee
Novaliq GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq GmbH filed Critical Novaliq GmbH
Publication of AU2019342426A1 publication Critical patent/AU2019342426A1/en
Priority to AU2025204313A priority Critical patent/AU2025204313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2019342426A 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness Abandoned AU2019342426A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025204313A AU2025204313A1 (en) 2018-09-22 2025-06-10 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP18196126.9 2018-09-22
EP18196126 2018-09-22
EP18198440 2018-10-03
EP18198440.2 2018-10-03
EP18202041.2 2018-10-23
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025204313A Division AU2025204313A1 (en) 2018-09-22 2025-06-10 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (1)

Publication Number Publication Date
AU2019342426A1 true AU2019342426A1 (en) 2021-05-20

Family

ID=68240699

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019342426A Abandoned AU2019342426A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
AU2025204313A Pending AU2025204313A1 (en) 2018-09-22 2025-06-10 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025204313A Pending AU2025204313A1 (en) 2018-09-22 2025-06-10 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Country Status (11)

Country Link
US (2) US20210346313A1 (https=)
EP (1) EP3852734A1 (https=)
JP (1) JP2022500461A (https=)
KR (1) KR20210080388A (https=)
CN (1) CN112739335A (https=)
AU (2) AU2019342426A1 (https=)
CA (1) CA3111873A1 (https=)
IL (1) IL281516A (https=)
PH (1) PH12021550621A1 (https=)
SG (1) SG11202102818YA (https=)
WO (1) WO2020058504A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
PT3442480T (pt) 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2018055101A1 (en) 2016-09-23 2018-03-29 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
EP4374851B1 (en) 2016-12-23 2026-04-15 Novaliq GmbH Ophthalmic composition for treatment of dry eye disease
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
MX2020003534A (es) 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8
KR20200128407A (ko) 2018-03-02 2020-11-12 노바리크 게엠베하 네비볼롤을 포함하는 약제학적 조성물
SG11202007860XA (en) 2018-03-28 2020-09-29 Novaliq Gmbh Pharmaceutical composition comprising timolol
CN112153970A (zh) 2018-04-27 2020-12-29 诺瓦利克有限责任公司 用于治疗青光眼的包含他氟前列素的眼用组合物
EP3923907B1 (en) 2019-02-13 2024-09-25 Novaliq GmbH Compositions and methods for the treatment of ocular neovascularization
KR20220058577A (ko) 2019-09-06 2022-05-09 노바리크 게엠베하 포도막염 치료를 위한 안과용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
EP2187900B1 (en) * 2007-08-16 2016-11-09 The Schepens Eye Research Institute, Inc. Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
AU2013314303B2 (en) * 2012-09-12 2018-01-18 Novaliq Gmbh Semifluorinated alkane compositions
CN113679699B (zh) * 2012-09-12 2022-10-28 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
JP5982070B1 (ja) * 2014-10-09 2016-08-31 株式会社メディプロデュース まつ毛用洗浄剤
CN110403923B (zh) * 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
CA3036297C (en) * 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2019068763A1 (en) * 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8

Also Published As

Publication number Publication date
KR20210080388A (ko) 2021-06-30
SG11202102818YA (en) 2021-04-29
PH12021550621A1 (en) 2022-02-14
CN112739335A (zh) 2021-04-30
AU2025204313A1 (en) 2025-06-26
EP3852734A1 (en) 2021-07-28
US20250295607A1 (en) 2025-09-25
IL281516A (en) 2021-04-29
US20210346313A1 (en) 2021-11-11
WO2020058504A1 (en) 2020-03-26
CA3111873A1 (en) 2020-03-26
JP2022500461A (ja) 2022-01-04

Similar Documents

Publication Publication Date Title
US20250295607A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
US12569452B2 (en) Ophthalmic compositions comprising F6H8
US12059449B2 (en) Ophthalmic composition for treatment of dry eye disease
JP6994061B2 (ja) ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
HK1201042A1 (en) Compositions for the treatment of dry eye
JP2025004186A (ja) 眼表面疼痛を治療する方法
RU2806212C2 (ru) Офтальмологические композиции для лечения повреждения поверхности глаза и симптомов сухости глаз
CA3076567C (en) Ophthalmic compositions comprising f6h8
RU2828769C2 (ru) Офтальмологические композиции для лечения синдрома сухого глаза
HK40114301A (en) Ophthalmic composition for treatment of dry eye disease
RU2850452C2 (ru) Способы лечения боли на поверхности глаза
HK40028751A (en) Ophthalmic compositions comprising f6h8
HK40058504B (en) Ophthalmic composition for treatment of dry eye disease
HK40058504A (en) Ophthalmic composition for treatment of dry eye disease
Lane the Eyedrop

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted